Cargando…

Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells

BACKGROUND: Chemoresistance is a major factor involved in a poor response and reduced overall survival in patients with advanced breast cancer. Although extensive studies have been carried out to understand the mechanisms of chemoresistance, many questions remain unanswered. METHODS: In this researc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Harris, Vo, The, Hajar, Ali, Li, Sarah, Chen, Xinmei, Parissenti, Amadeo M, Brindley, David N, Wang, Zhixiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900991/ https://www.ncbi.nlm.nih.gov/pubmed/24447372 http://dx.doi.org/10.1186/1471-2407-14-37

Ejemplares similares

Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents
por: Wang, Richard C., et al.
Publicado: (2017)

Role of autophagy and lysosomal drug sequestration in acquired resistance to doxorubicin in MCF-7 cells
por: Guo, Baoqing, et al.
Publicado: (2016)

Distinct genetic alterations occur in ovarian tumor cells selected for combined resistance to carboplatin and docetaxel
por: Armstrong, Stephen R, et al.
Publicado: (2012)

Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells
por: Sprowl, Jason A, et al.
Publicado: (2012)

Docetaxel: an alternative taxane in ovarian cancer
por: Katsumata, N
Publicado: (2003)

Fatty acid binding protein 5 regulates docetaxel sensitivity in taxane-resistant prostate cancer cells
por: Hillowe, Andrew, et al.
Publicado: (2023)

Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells
por: Chewchuk, Simon, et al.
Publicado: (2017)

Mechanisms of Taxane Resistance
por: Maloney, Sara M., et al.
Publicado: (2020)

Genetics and Expression Profile of the Tubulin Gene Superfamily in Breast Cancer Subtypes and Its Relation to Taxane Resistance
por: Nami, Babak, et al.
Publicado: (2018)

Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance
por: Edwardson, Derek W., et al.
Publicado: (2017)

ABCB1 Amplicon Contains Cyclic AMP Response Element-Driven TRIP6 Gene in Taxane-Resistant MCF-7 Breast Cancer Sublines
por: Daniel, Petr, et al.
Publicado: (2023)

Glutathione S-transferases (GSTs) polymorphism and taxane (docetaxel) sensitivity in breast cancer
por: Lee, Anbok
Publicado: (2019)

SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells
por: Zheng, Xiaowei, et al.
Publicado: (2017)

SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells
por: Zheng, Xiaowei, et al.
Publicado: (2022)

SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells
por: Zheng, Xiaowei, et al.
Publicado: (2023)

Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration
por: Zhou, Changhua, et al.
Publicado: (2012)

Prediction of Acquired Taxane Resistance Using a Personalized Pathway-Based Machine Learning Method
por: Kim, Young Rae, et al.
Publicado: (2019)

A study of Docetaxel-induced effects in MCF-7 cells by means of Raman microspectroscopy
por: Hartmann, Katharina, et al.
Publicado: (2012)

Co-encapsulation of thymoquinone with docetaxel enhances the encapsulation efficiency into PEGylated liposomes and the chemosensitivity of MCF7 breast cancer cells to docetaxel
por: Odeh, Fadwa, et al.
Publicado: (2019)

Enhanced anti-tumor efficacy and mechanisms associated with docetaxel-piperine combination- in vitro and in vivo investigation using a taxane-resistant prostate cancer model
por: Li, Chenrui, et al.
Publicado: (2017)

Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines
por: Donix, Lukas, et al.
Publicado: (2022)

Targeting mTOR Complex 2 in Castration-Resistant Prostate Cancer with Acquired Docetaxel Resistance
por: Huang, Yujie, et al.
Publicado: (2022)

ERG induces taxane resistance in castration-resistant prostate cancer
por: Galletti, Giuseppe, et al.
Publicado: (2014)

Transferrin-Conjugated Docetaxel–PLGA Nanoparticles for Tumor Targeting: Influence on MCF-7 Cell Cycle
por: Jose, Sajan, et al.
Publicado: (2019)

Targeting LIM kinases in taxane resistant tumors
por: Prunier, Chloé, et al.
Publicado: (2016)

Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
por: Wang, Xu, et al.
Publicado: (2019)

A Critical Dose of Doxorubicin Is Required to Alter the Gene Expression Profiles in MCF-7 Cells Acquiring Multidrug Resistance
por: Tsou, Shang-Hsun, et al.
Publicado: (2015)

Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia
por: Syu, Jhih-Pu, et al.
Publicado: (2016)

Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
por: Bumbaca, Brandon, et al.
Publicado: (2018)

Prostate apoptosis response-4 is involved in the apoptosis response to docetaxel in MCF-7 breast cancer cells
por: PEREIRA, MICHELLY C., et al.
Publicado: (2013)

Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
por: Wang, Xu, et al.
Publicado: (2020)

Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization
por: Heibein, Allan D, et al.
Publicado: (2012)

Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan
por: Hiscox, Stephen, et al.
Publicado: (2012)

Differential regulation of specific genes in MCF-7 and the ICI 182780-resistant cell line MCF-7/182(R)-6
por: Jensen, B L, et al.
Publicado: (1999)

Hyaluronic acid-coated chitosan nanoparticles as targeted-carrier of tamoxifen against MCF7 and TMX-resistant MCF7 cells
por: Nokhodi, Fariba, et al.
Publicado: (2022)

A Novel Electrochemical Differentiation between Exosomal-RNA of Breast Cancer MCF7 and MCF7/ADR-Resistant Cells
por: Abdelaziz, Mohammed H., et al.
Publicado: (2023)

Mutations in BRCA2 and taxane resistance in prostate cancer
por: Nientiedt, Cathleen, et al.
Publicado: (2017)

Platinum drugs and taxanes: can we overcome resistance?
por: Sazonova, Elena V., et al.
Publicado: (2021)

Long Noncoding RNAs in Taxane Resistance of Breast Cancer
por: Chen, Hailong, et al.
Publicado: (2023)

Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance
por: Hembruff, Stacey L, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_21s1n483eg370h0b31nnl33a9t